Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.

about

Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.

Item

http://www.wikidata.org/entity/Q47196467

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Moxifloxacin versus levofloxac ...... is in acute leukemia patients.

@en

Moxifloxacin versus levofloxac ...... is in acute leukemia patients.

@nl

type

Item

label

Moxifloxacin versus levofloxac ...... is in acute leukemia patients.

@en

Moxifloxacin versus levofloxac ...... is in acute leukemia patients.

@nl

prefLabel

Moxifloxacin versus levofloxac ...... is in acute leukemia patients.

@en

Moxifloxacin versus levofloxac ...... is in acute leukemia patients.

@nl

P1476

Moxifloxacin versus levofloxac ...... is in acute leukemia patients.

@en

P2093

Jennifer Pisano

http://www.w3.org/2001/XMLSchema#string

Natasha N Pettit

http://www.w3.org/2001/XMLSchema#string

Pauline Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.

Anthracycline dose intensification in acute myeloid leukemia.

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.

Moxifloxacin prophylaxis in neutropenic patients.

High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).

P304

758-761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155217752074

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Randall W Knoebel

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29310512

http://www.w3.org/2001/XMLSchema#string